Arbutus Biopharma (ABUS) EPS (Basic) (2013 - 2026)
Arbutus Biopharma (ABUS) posted quarterly EPS (Basic) of $0.88 for Q1 2026, up 780.88% year-on-year from $0.1 in Q1 2025, and up 3477.62% on a QoQ basis from -$0.03 in Q4 2025.
Arbutus Biopharma (ABUS) EPS (Basic) (2013 - 2026) Analysis & Trends
Arbutus Biopharma (ABUS) has reported EPS (Basic) for 14 consecutive years, with $0.88 the latest figure, recorded in Q1 2026.
- Quarterly EPS (Basic) rose 780.88% year-over-year to $0.88 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $0.82 (up 304.93% YoY) and the FY2025 annual result came in at -$1.12, down 198.55% from the prior year.
- EPS (Basic) climbed to $0.88 in Q1 2026 per ABUS's latest filing, from -$0.03 in the prior quarter.
- Over the last five years, EPS (Basic) for ABUS reached as high as $0.88 in Q1 2026 and fell as low as -$0.15 in Q4 2022.
- A 5-year average of -$0.03 and a median of -$0.1 in 2023 frame the typical range for EPS (Basic).
- Annual changes were most pronounced in 2025 — EPS (Basic) retreated 25.6% — and 2026, when it jumped 780.88%.
- Year by year, EPS (Basic) stood at -$0.15 in 2022, then grew by 19.92% to -$0.12 in 2023, then soared by 42.13% to -$0.07 in 2024, then surged by 61.5% to -$0.03 in 2025, then jumped by 3477.62% to $0.88 in 2026.
- According to Business Quant data, EPS (Basic) over the past three periods registered $0.88, -$0.03, and -$0.04 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 0.00 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 0.16 |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 0.00 |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 4.06 |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 6.99 |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | 0.00 |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 7.59 |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -2.29 |
| 10 | Arbutus Biopharma | 880.36 Mn | 785.13 Mn | - | 0.88 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 0.88 |
| Dec 31, 2025 | -0.03 |
| Sep 30, 2025 | -0.04 |
| Jun 30, 2025 | 0.01 |
| Mar 31, 2025 | -0.13 |
| Dec 31, 2024 | -0.07 |
| Sep 30, 2024 | -0.10 |
| Jun 30, 2024 | -0.11 |
| Mar 31, 2024 | -0.10 |
| Dec 31, 2023 | -0.12 |
| Sep 30, 2023 | -0.12 |
| Jun 30, 2023 | -0.10 |
| Mar 31, 2023 | -0.10 |
| Dec 31, 2022 | -0.15 |
| Sep 30, 2022 | -0.12 |
| Jun 30, 2022 | -0.10 |
| Mar 31, 2022 | -0.11 |
| Dec 31, 2021 | -0.21 |
| Sep 30, 2021 | -0.24 |
| Jun 30, 2021 | -0.23 |